title: Sumatriptan/naproxen sodium combination versus its components administered concomitantly for the acute treatment of migraine: a pragmatic, crossover, open-label outcomes study.
abstract: OBJECTIVE
  Efficacy and tolerability profiles of Treximet [sumatriptan/naproxen sodium combination tablet (SNC)] have been established in clinical trials but have to date been virtually unstudied in pragmatic research. The primary objective of this study was to compare the overall satisfaction of SNC to its monotherapy components, S/N [one 100 mg Imitrex tablet (S) and two Aleve (naproxen sodium) 220 mg tablets, total dose 440 mg (N)] administered concomitantly using the Patient Perception of Migraine Questionnaire -Revised (PPMQ-R).
  
  
  METHODS
  Adults with migraine (n = 50) without 'medication overuse headache' were treated for up to 18 migraine attacks per 3-month study period with study medication; SNC during one study period and S/N during the other study period. For all endpoints, differences between treatments were compared with paired t tests.
  
  
  RESULTS
  The percentage of patients reporting satisfied/very satisfied for Overall Satisfaction of SNC versus S/N (primary endpoint) was 85% versus 72% respectively (p = 0.054). For Overall Effectiveness, the results were 82% for SNC versus 73% for S/N (p = 0.159); and for Overall Side Effects the results were 86% for SNC versus 69% for S/N (p = 0.005). Mean PPMQ-R scores reflect greater satisfaction with SNC than S/N for Total score and for each of four subscales. The difference between SNC and S/N was significant for the Ease of Use subscale (p = 0.004) and met the criterion of being clinically meaningful for both the Total score and Ease of Use. SNC did not differ from S/N with respect to pain-free response 2 h post dose, pain relief 2 h post dose, sustained 24 h pain-free response, or sustained 24 h pain relief.
  
  
  CONCLUSIONS
  Although the primary endpoint only just failed, the results of this pragmatic outcomes study demonstrate SNC to have benefits over its concomitantly administered components in the acute treatment of migraine.
authors.affiliation: Wesley Neurology and Headache Clinic, University of Tennessee Medical School, 8000 Centerview Parkway, Suite 101, Memphis, TN 38018, USA.
authors.forename: Stephen
authors.initials: S
authors.lastname: Landy
authors.forename: Rebecca
authors.initials: R
authors.lastname: Hoagland
authors.forename: Dakota
authors.initials: D
authors.lastname: Hoagland
authors.forename: Jane
authors.initials: J
authors.lastname: Saiers
authors.forename: Gena
authors.initials: G
authors.lastname: Reuss
keywords: headache; migraine; naproxen sodium; patient treatment satisfaction; sumatriptan